Trial Profile
Partial treatment interruptions in HIV-1 patients with multi-drug resistant virus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Enfuvirtide (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 23 Feb 2009 Additional trial centres added as reported by ClinicalTrials.gov, last updated 23 Feb 2009.
- 23 Feb 2009 Additional trial investigator Deeks SG reported by ClinicalTrials.gov, last updated 23 Feb 2009.
- 23 Feb 2009 Patient numbers amended from 50 to 25 as reported by ClinicalTrials.gov.